APA (7th ed.) Citation

M, V., D, G., F, Z., C, C., V, B., G, I., . . . M, R. (2022). Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: A pre-specified, open-label, extension study. Therapeutic advances in musculoskeletal disease, 14, 1759720X221142274. https://doi.org/10.1177/1759720X221142274

Chicago Style (17th ed.) Citation

M, Varenna, Gatti D, Zucchi F, Crotti C, Braga V, Iolascon G, Frediani B, Nannipieri F, and Rossini M. "Long-term Efficacy and Safety of Neridronate Treatment in Patients with Complex Regional Pain Syndrome Type 1: A Pre-specified, Open-label, Extension Study." Therapeutic Advances in Musculoskeletal Disease 14 (2022): 1759720X221142274. https://doi.org/10.1177/1759720X221142274.

MLA (9th ed.) Citation

M, Varenna, et al. "Long-term Efficacy and Safety of Neridronate Treatment in Patients with Complex Regional Pain Syndrome Type 1: A Pre-specified, Open-label, Extension Study." Therapeutic Advances in Musculoskeletal Disease, vol. 14, 2022, p. 1759720X221142274, https://doi.org/10.1177/1759720X221142274.